Performance funds/ETFs
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€223,15
Quote date
01-04-2026
Performance in EUR
Date
01-04-2026
This year
-0,69%
1 week
3,25%
1 month
-5,62%
3 months
-0,69%
6 months
4,33%
1 year
2,21%
3 years (annualised)
4,62%
5 years (annualised)
6,74%
Since start (annualised)
7,65%
Indicators
Standard deviation (3yr)
15,00%
Share ratio (3yr)
0,15
Beta (3yr)
1,05
Alpha (3yr)
0,94
Tracking error (3yr)
7,27
Top 10 holdings (28-02-2026)
Roche Holding AG
19,79 %
AstraZeneca PLC
19,12 %
Novartis AG Registered Shares
19,04 %
Novo Nordisk AS Class B
7,15 %
Sanofi SA
6,33 %
Essilorluxottica
4,72 %
Lonza Group Ltd
2,89 %
Haleon PLC
2,87 %
argenx SE
2,82 %
Alcon Inc
2,56 %
Fees
Entry fee
->Tarievenkaart / Cost information sheet
Exit charges
->Tarievenkaart / Cost information sheet
Estimated ongoing charges
0,17%
Dividend
Dividend paying
No
Characteristic
Asset Manager
Xtrackers
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Passief etf
Fund code
241286
Fund code fractional orders
-
Fund manager name
Not Disclosed
ISIN
LU0292103222
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Luxembourg
Currency
EUR
Fund size (mio)
259,06 (31-03-2026)
Cut-off time
-
Execution date
niet van toepassing: directe verhandeling op de beurs
Inception date
26-06-2007
Benchmark
MSCI Euro HlCr ESG Scrn 20-35 Sel NR EUR
Minimum investment amount
-
Assortiment
Self Directed Investing Plus, Investment advice